TCL Archive Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker October 3, 2014
TCL Archive Conferees Set $1.991 Bil. NCI Budget, Ax Earmark For Breast Cancer, But Find $210 Mil. In Defense October 9, 1992
TCL Archive As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study November 21, 2014
